The counter-regulatory (beneficial) effects of aldosterone mediated by GPER activation in the vasculature are decreased in diabetes mellitus, whereas vascular pro-contractile aldosterone effects are maintained. This evidence concerns the gene GPER1 and diabetes mellitus.